Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Medtronic
Merck
Fuji
Covington

Generated: July 20, 2019

DrugPatentWatch Database Preview

Patent: 7,807,683

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,807,683
Title:N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
Abstract: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
Inventor(s): Guzi; Timothy J. (Chatham, NJ), Paruch; Kamil (Garwood, NJ), Dwyer; Michael P. (Scotch Plains, NJ), Doll; Ronald J. (Convent Station, NJ), Girijavallabhan; Viyyoor M. (Parsippany, NJ), Mallams; Alan (Hackettstown, NJ), Alvarez; Carmen S. (Livingston, NJ), Keertikar; Kartik M. (East Windsor, NJ), Rivera; Jocelyn (Monmouth Junction, NJ), Chan; Tin Yau (Edison, NJ), Madison; Vincent (Mountain Lakes, NJ), Fischmann; Thierry O. (Scotch Plains, NJ), Dillard; Lawrence W. (Skillman, NJ), Tran; Vinh D. (Fountain Valley, CA), He; Zhen Min (Princeton, NJ), James; Ray Anthony (Bensalem, PA), Park; Haengsoon (Plainsboro, NJ), Paradkar; Vidyadhar M. (Somerville, NJ), Hobbs; Douglas Walsh (Yardley, PA)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:11/396,001
Patent Claims:see list of patent claims

Details for Patent 7,807,683

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial Schering Corporation (Kenilworth, NJ) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Citi
Johnson and Johnson
Deloitte
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.